Immunohistochemistry of matrix metalloproteinases and their inhibitors in thoracic aortic aneurysms and aortic valves of patients with Marfan's syndrome

Circulation

Volumn 98, Issue 19 SUPPL., 1998, Pages

  Segura, Ana M ^a   Luna, Rafael E ^b   Horiba, Koji ^b   Stetler Stevenson, William G ^c   McAllister Jr , Hugh A ^a   Willerson, James T ^a   Ferrans, Victor J ^b  

^a ST LUKE S EPISCOPAL HOSPITAL   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Aneurysms; Aorta; Collagen; Immunohistochemistry; Metalloproteinases; Pathology; Va lves

Indexed keywords

COLLAGENASE; ELASTIN; GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE;

ADOLESCENT; ADULT; AORTA VALVE REGURGITATION; ARTICLE; CLINICAL ARTICLE; DISEASE ASSOCIATION; ENZYME ASSAY; ENZYME LOCALIZATION; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MARFAN SYNDROME; PRIORITY JOURNAL; SCHOOL CHILD; SMOOTH MUSCLE FIBER; THORACIC AORTA ANEURYSM; VASCULAR SMOOTH MUSCLE;

ADOLESCENT; ADULT; AORTA, THORACIC; AORTIC ANEURYSM, THORACIC; AORTIC VALVE; CHILD; EXTRACELLULAR MATRIX; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MARFAN SYNDROME; MATRIX METALLOPROTEINASE 3; METALLOENDOPEPTIDASES; MIDDLE AGED;

EID: 0345487517     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Pyeritz RE, McKusick VA. The Marfan syndrome: diagnosis and management. N Engl J Med. 1979;300:772-777.
2. McKusick VA. The cardiovascular aspects of Marfan's syndrome: a heritable disorder of connective tissue. Circulation. 1955;11:321-342.
3. Roberts WC, Honig HS. The spectrum of cardiovascular disease in the Marfan syndrome: a clinico-morphologic study of 18 necropsy patients and comparison to 151 previously reported necropsy patients. Am Heart J. 1982;104:115-135.
4. Murdoch JL, Walker BA, Halpem BL, Kuzma JW, McKusick VA. Life expectancy and causes of death in the Marfan syndrome. N Engl J Med. 1972;286:804-808.
5. Chaikof E, Smith R III. Congenital Aortic Aneurysms In: Yao JT, Pearce W. Aneurysms: New Findings and Treatments. Norwalk, Conn: Appleton and Lange; 1994:353-356.
6. Erdheim J. Medionecrosis aortae idiopathica. Virchows Arch. 1929;273: 454-479.
7. Francke U, Furthmayr H. Marfan's syndrome and other disorders of fibrillin. N Engl J Med. 1994;330:1384-1385.
8. Perejola AJ, Abraham PA, Carnes W, Uilto J. Marfan syndrome: structural, biochemical and mechanical studies of the aortic media. J Lab clin Med. 1985;106:376-383.
9. Dollery C. McEwan J, Henney A. Matrix metalloproteinases and cardiovascular disease. Circ Res. 1995;77:863-868.
10. Stetler-Stevenson WG, Hewitt R, Corcoran M. Matrix metalloproteinases and tumor invasion: from correlation and causality to the clinic. Cancer Biol. 1996;7:147-154.
11. Newman K, Jean-Claude J, Li H, Sholes J, Ogata Y, Nagase H, Tilson MD. Cellular localization of matrix metalloproteinases in the abdominal aortic aneurysm wall. J Vasc Surg. 1994;20:814-820.
12. Knox J, Sukhova G, Whittemore A, Libby P. Evidence for altered balance between matrix metalloproteinases and their inhibitors in human aortic diseases. Circulation. 1997;95:205-212.
13. Tilson MD, Newman K. Proteolytic mechanisms in the pathogenesis of aortic aneurysms. In: Yao JT, Pearce W. Aneurysms: New Findings and Treatments. Norwalk, Conn: Appleton and Lange; 1994:3-10.
14. Thompson RW, Parks WC. Role of matrix metalloproteinases in abdominal aortic aneurysms. Ann N Y Acad Sci. 1996;800:157-174.
15. McMillan WD, Patterson BK, Keen RR, Shively VP, Cipollone M, Pearce WH. In situ localization and quantification of mRNA for 92-kD type IV collagenase and its inhibitor in aneurysmal, occlusive, and normal aorta. Arterioscler Thromb Vasc Biol. 1995;15:1139-1144.
16. Thompson RW, Holmer DR, Mertens RA, Liao S, Botney MD, Mecham RP, Welgus HG, Parks WC. Production and localization of 92-kilodalton gelatinase in abdominal aortic aneurysms: an elastolytic metalloproteinase expressed by aneurysm-infiltrating macrophages. J Clin Invest. 1995;96:318-326.
17. McMillan WD, Patterson BK, Keen RR, Pearce WH. In situ localization and quantification of seventy-two-kilodalton type IV collagenase in aneurysmal, occlusive, and normal aorta. J Vasc Surg. 1995;22:295-305.
18. Brophy CM, Marks WH, Reilly JM, Tilson MD. Decreased tissue inhibitor of metalloproteinase (TIMP) in abdominal aortic aneurysm tissue: a preliminary report. J Surg Res. 1991;50:653-657.
19. Hayashi T, Stetler-Stevenson WG, Flemming MV, Fishback N, Koss MN, Liotta LA, Ferrans VJ, Travis WD. Immunohistochemical study of metalloproteinases and their tissue inhibitors in the lungs of patients with diffuse alveolar damage and idiopathic pulmonary fibrosis. Am J Pathol. 1996;149:1241-1256.
20. Horiba K, Luna RE, Usuki J, Paakko P, Kaplan M, Liotta LA, Stetler-Stevenson WG, Travis WD, Ferrans VJ. Immunohistochemical study of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in emphysema. Am J Respir Crit Care Med. 1997;151:A586. Abstract.
21. Hayashi T, Fleming MV, Stetler-Stevenson WG, Liotta LA, Moss J, Ferrans VJ, Travis WD. Immunohistochemical study of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in pulmonary lymphangioleiomyomatosis (LAM). Hum Pathol. 1997;28:1071-1078.
22. Hayashi T, Rush W, Travis WD, Liotta LA, Stetler-Stevenson WG, Ferrans VJ. Immunohistochemical study of matrix metalloproteinases and their tissue inhibitors in pulmonary Langerhans' cell granulomatosis. Arch Pathol Lab Med. 1997;121:930-937.
23. Nakagawa H, Yagihashi S. Expression of type IV collagen and its degrading enzymes in squamous cell carcinoma of the lung. Jpn J Cancer Res. 1994;85:934-938.
24. Galateau-Salle FB, Luna RE, Horiba K. Sheppard MN, Hayashi T, Fleming MV, Colby TV, Bennett W, Harris CC, Stetler-Stevenson WG, Liotta LA, Ferrans VJ, Travis WD. Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in bronchial squamous preneoplastic lesions. Mod Pathol. 1998;11:174A. Abstract.
25. Marsalese D, Moodie D, Lytle B, Cosgrove D, Ratliff N, Goormastic M, Kovacs A. Cystic medial necrosis of the aorta in patients without Marfan's syndrome: surgical outcome and long-term follow-up. J Am Coll Cardiol. 1990;16:68-73.
26. Fox B. Cystic medial necrosis. In: Greenhalgh RM, Mannick JA, eds. The Cause and Management of Aneurysms. London, UK: WB Saunders Co; 1990:79-87.
27. Isner JM, Donaldson RF, Fulton D, Bhan I, Payne DD, Cleveland RJ. Cystic medial necrosis in coarctation of the aorta: a potential factor contributing to adverse consequences observed after percutaneous balloon angioplasty of coarctation sites. Circulation. 1987;75:689-695.
28. Lin AE, Lippe BM, Geffner ME, Gomes A, Lois JF, Barton CW, Rosenthal A, Friedman WF. Aortic dilation, dissection, and rupture in patients with Turner syndrome. J Pediatr. 1986;109:820-826.
29. Somlo S, Rutecki G, Giuffra LA, Reeders ST, Cugino A, Whittier FC. A kindred exhibiting cosegregation of an overlap connective tissue disorder and the chromosome 16 linked form of autosomal dominant polycystic kidney disease. J Am Soc Nephrol. 1993;4:1371-1378.
30. th ed. St Louis, Mo: CV Mosby Co; 1993:51-135.
31. Powell J, Greenhalgh RM. Cellular, enzymatic, and genetic factors in the pathogenesis of abdominal aortic aneurysms. J Vasc Surg. 1989;9: 297-304.